Tech Nation + BioTech Nation + Global BioEntrepreneurship
Weekly Public Radio Program & Podcast
Episode 26-03Air Date: January 21, 2026
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
Episode 26-02 Air Date: January 14, 2026
On this week’s Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.
Episode 26-01Air Date: January 7, 2026
On this week’s Tech Nation, with the 44th Annual J.P. Morgan Healthcare Conference around the corner, we delve into three ongoing efforts in biotech. Moira speaks with Cyriac Roeding and Dr David Suhy, Co-Founders of Earli, about their innovative approach to treating solid tumour cancer. Then, Ketan Mehta of Tris Pharma discusses the potential of a euphoria-suppressing opioid. And Neil Klompas of Augurex Life Sciences talks about a new diagnostic for patients with chronic back pain that pinpoints an easily-missed form of arthritis.
The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
BioTech Nation PODCASTS
January 20, 2026
Dr. Barry Quart CEO, Connect Biopharma
  • On this episode of BioTech Nation, Moira speaks with Dr. Barry Quart, CEO of Connect Biopharma, about a new fast-acting treatment for inflammatory conditions like Asthma, COPD, and Eczema.
  • Often, these conditions can be managed with anti-inflammatory therapeutics like Dupixent, but even then, sudden and painful flare-ups can occur. We take a closer look at a new anti-inflammatory in late-stage development which starts working quickly, much needed when those flare-ups develop.
January 13, 2026
A Speedy Intervention for Heart Attacks Dr. Harry Selker & Dr. Atul Deshpande, IMMEDIATE Therapeutics
On this episode of BioTech Nation, Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away... potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms.
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.